STEVEN WOLF: Open Payments
NPI 1487645693 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$48,371 in 156 payments from 29 companies in 2025. Trend: 2023 $62,283 · 2024 $45,370 · 2025 $48,371
Speaker / faculty: $34,985Consulting: $5,926Food & beverage: $4,448Travel & lodging: $3,011
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 25 | $13,829 |
| UCB Biosciences Inc. | 2 | $8,500 |
| Neurelis, Inc. | 14 | $8,147 |
| UCB, Inc. | 30 | $7,671 |
| Monteris Medical Corporation | 14 | $4,498 |
| Otter Pharmaceuticals, LLC | 7 | $2,778 |
| LivaNova USA, Inc. | 2 | $1,440 |
| SK Life Science, Inc. | 17 | $487 |
| Supernus Pharmaceuticals, Inc. | 11 | $202 |
| AQUESTIVE THERAPEUTICS, INC. | 2 | $115 |
Products named: Fintepla, EPIDIOLEX, VALTOCO, Neuroblate, SYMPAZAN, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, Qelbree, Briviact.
Industry payments across NY — which companies pay providers there.
